Drugs / DWJ1276
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01764295 | Sep 2012 → May 2013 | hyperlipidemia, hypertensive disorder | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWJ1276 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01764295 ↗ |
| Route | Oral | “Once daily, administered orally, 8 week” NCT01764295 ↗ |